FINWIRES · TerminalLIVE
FINWIRES

Middle East Outlook Elevates European Bourses Midday

-- European bourses tracked moderately higher midday Tuesday on renewed hopes for a resumption in Tehran-Washington peace negotiations, and as relative calm prevailed in the Strait of Hormuz as US Navy ships patrolled the waters.

Tech and property stocks led gains on continental trading floors, while oil shares lagged.

Investors also eyed Wall Street futures in the green, and higher closes overnight on Asian exchanges, led by a 2.7% rise on Seoul's KOSPI index.

The pan-continental Stoxx Europe 600 Index was up 0.6% mid-session.

The Stoxx Europe 600 Technology Index was up 1.9%, and the Stoxx 600 Banks Index gained 0.6%.

The Stoxx Europe 600 Oil and Gas Index was flat, while the Stoxx 600 Europe Food and Beverage Index inclined 0.7%.

The REITE, a European REIT index, rose 1.2%.

On the national market indexes, Germany's DAX was up 0.9%, and the FTSE 100 in London gained 0.1%. The CAC 40 in Paris was up 0.6%, and Spain's IBEX 35 lifted 0.6%.

Yields on benchmark 10-year German bonds were lower, near 3.07%.

Front-month North Sea Brent crude-oil futures were holding under $100 a barrel, near $99.30.

The Euro Stoxx 50 volatility index was down 8.1% at 20.96, still modestly indicating above-average volatility for European stock markets in the next 30 days, a negative signal. A reading above 20 indicates choppier markets ahead, while below 20 suggests calmer exchanges.

相关文章

Asia

Dizal Pharma将在美国临床肿瘤学会年会上公布三种药物的研究成果。

据周三在上海证券交易所发布的公告显示,江苏迪扎尔制药(SHA:688192)表示,将在美国临床肿瘤学会(ASCO)年会上公布其新药sunvozertinib片剂、golidocitinib胶囊和DZD6008的最新研究成果。 sunvozertinib和DZD6008均用于治疗非小细胞肺癌,而golidocitinib则用于治疗T细胞淋巴瘤。研究结果显示,这些药物均取得了积极成果,尤其是DZD6008,其具有显著的抗肿瘤活性且安全性良好。 该生物技术公司的股价在午盘交易中上涨不到2%。

$SHA:688192
Asia

Critica将于3月季度启动西澳大利亚稀土项目范围界定研究。

据周三提交给澳大利亚证券交易所的文件显示,Critica(ASX:CRI)表示,位于西澳大利亚的Jupiter稀土项目的初步研究已于今年3月季度正式启动。 该研究整合了选矿、下游加工、基础设施和开发假设,旨在确定一个基准开发路径。 公司计划在6月季度继续完成Jupiter项目140个钻孔的资源升级钻探工作。此外,公司还计划准备并运送20,000公斤散装样品进行中试规模处理,以支持持续的优化、性能提升和中间精矿的生产。

$ASX:CRI
Asia

北太平洋银行的收购要约确保了对卡里尔银行的控制权

北太平洋银行(东京证券交易所代码:8524)周三在东京证券交易所发布公告称,其对Career Bank的股份收购要约已获成功,持股比例增至88.26%,使Career Bank成为其子公司。 北太平洋银行此次收购了852,487股Career Bank股份,超过了完成交易所需的最低收购数量。 结算将于4月28日开始,届时Career Bank将正式并入北太平洋银行的财务报表。 北太平洋银行计划启动相关程序,使Career Bank成为其全资子公司,并将其股票从札幌证券交易所退市。此次收购总成本约为15亿日元。

$TYO:8524